pI: 6.7702 |
Length (AA): 1372 |
MW (Da): 151552 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
785 | 1247 | 1k9a (A) | 37 | 436 | 21.00 | 0 | 1 | 0.34 | 0.93 |
835 | 1369 | 1omw (A) | 29 | 554 | 16.00 | 0 | 1 | 0.17 | 1.12 |
989 | 1251 | 1mq4 (A) | 130 | 381 | 30.00 | 0 | 1 | 0.62 | -1.14 |
221 | 270 | 2nbi (A) | 436 | 490 | 52.00 | 0.14 | 0.05 | 0.419743 | -0.37 |
482 | 731 | 5cwq (A) | 13 | 232 | 22.00 | 0 | 0.4 | 0.301816 | -1.16 |
484 | 675 | 4uos (A) | 7 | 187 | 12.00 | 0 | 0.13 | 0.345542 | -2.5 |
793 | 1247 | 1fmk (A) | 91 | 512 | 21.00 | 0 | 1 | 0.359433 | 0.85 |
824 | 1372 | 3uzs (A) | 29 | 551 | 18.00 | 0 | 1 | 0.348946 | 1.14 |
988 | 1300 | 3gbz (A) | 11 | 307 | 43.00 | 0 | 1 | 0.635934 | -0.45 |
1095 | 1139 | 4ix3 (A) | 296 | 342 | 47.00 | 0.36 | 0.98 | 0.443099 | 0.79 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 Oocyst, ME49 Bradyzoite. | Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite. | Gregory Hehl AB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Sibley/Greg | ToxoDB |
Gregory | ToxoDB |
Ortholog group members (OG5_129183)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G67580 | putative serine/threonine protein kinase |
Babesia bovis | BBOV_II004380 | cdc-related protein kinase I |
Brugia malayi | Bm1_17240 | Protein kinase domain containing protein |
Brugia malayi | Bm1_13195 | hypothetical protein |
Caenorhabditis elegans | CELE_ZC504.3 | Protein ZC504.3 |
Caenorhabditis elegans | CELE_B0495.2 | Protein B0495.2 |
Dictyostelium discoideum | DDB_G0283279 | CDK family protein kinase |
Drosophila melanogaster | Dmel_CG4268 | CG4268 gene product from transcript CG4268-RA |
Echinococcus granulosus | EgrG_000528200 | cyclin dependent kinase 11B |
Echinococcus multilocularis | EmuJ_000528200 | cyclin dependent kinase 11B |
Homo sapiens | ENSG00000248333 | cyclin-dependent kinase 11B |
Homo sapiens | ENSG00000008128 | cyclin-dependent kinase 11A |
Loa Loa (eye worm) | LOAG_01264 | cmgc/cdk/pitslre protein kinase |
Loa Loa (eye worm) | LOAG_08905 | hypothetical protein |
Mus musculus | ENSMUSG00000029062 | cyclin-dependent kinase 11B |
Neospora caninum | NCLIV_001240 | hypothetical protein |
Oryza sativa | 4329899 | Os02g0602100 |
Oryza sativa | 4336224 | Os04g0488000 |
Plasmodium berghei | PBANKA_0719900 | cdc2-related protein kinase 1 |
Plasmodium falciparum | PF3D7_0417800 | cdc2-related protein kinase 1 |
Plasmodium knowlesi | PKNH_0510200 | cdc2-related protein kinase 1, putative |
Plasmodium vivax | PVX_089980 | cdc2-related protein kinase 1, putative |
Plasmodium yoelii | PY03317 | cdc-2 related kinase 1 |
Schistosoma japonicum | Sjp_0082800 | ko:K08818 cell division cycle 2-like, putative |
Schistosoma mansoni | Smp_176620 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.003556.02 | Serine/threonine-protein kinase PITSLRE |
Schmidtea mediterranea | mk4.007076.00 | Serine/threonine-protein kinase PITSLRE |
Schmidtea mediterranea | mk4.010725.00 | Serine/threonine-protein kinase PITSLRE |
Schmidtea mediterranea | mk4.044688.00 | Serine/threonine-protein kinase PITSLRE |
Schmidtea mediterranea | mk4.003707.02 | Serine/threonine-protein kinase PITSLRE |
Toxoplasma gondii | TGME49_304970 | cell-cycle-associated protein kinase CDK, putative |
Theileria parva | TP04_0551 | cell division cycle 2 protein kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_ZC504.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_B0495.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_B0495.2 | Caenorhabditis elegans | slow growth | wormbase |
CELE_B0495.2 | Caenorhabditis elegans | sterile | wormbase |
TGME49_304970 this record | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | cyclin-dependent kinase 11A | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 26.3% | 312 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 30.3% | 330 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 41.8% | 311 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 40.3% | 310 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 33.2% | 316 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 41.1% | 309 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-A | 361 aa | 25.9% | 321 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 8 | 411 aa | 30.4% | 339 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 41.2% | 311 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 37.9% | 190 aa | Compounds | References |